Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 8.115 Q1 | 391 | 317 | 492 | 7006 | 3213 | 170 | 6.53 | 22.10 |  |
| 2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.910 Q1 | 70 | 14 | 32 | 1993 | 245 | 32 | 8.04 | 142.36 |  |
| 3 | Trends in Pharmacological Sciences | journal | 3.825 Q1 | 244 | 117 | 489 | 5609 | 3267 | 392 | 7.46 | 47.94 | |
| 4 | Cellular and Molecular Life Sciences | journal | 3.027 Q1 | 261 | 275 | 615 | 23250 | 3400 | 606 | 5.09 | 84.55 |  |
| 5 | Apoptosis : an international journal on programmed cell death | journal | 2.441 Q1 | 128 | 84 | 172 | 4678 | 849 | 170 | 4.74 | 55.69 |  |
| 6 | Neuropsychopharmacology | journal | 2.241 Q1 | 249 | 250 | 659 | 13878 | 3291 | 620 | 4.75 | 55.51 | |
| 7 | Current Opinion in Pharmacology | journal | 2.009 Q1 | 148 | 100 | 307 | 4894 | 1450 | 282 | 4.93 | 48.94 | |
| 8 | Neuropharmacology | journal | 1.901 Q1 | 191 | 261 | 696 | 13239 | 2861 | 696 | 4.03 | 50.72 | |
| 9 | Psychopharmacology | journal | 1.798 Q1 | 214 | 370 | 997 | 18890 | 4002 | 948 | 3.64 | 51.05 | |
| 10 | Progress in Medicinal Chemistry | journal | 1.638 Q1 | 38 | 7 | 27 | 1827 | 95 | 23 | 2.79 | 261.00 | |
| 11 | Antiviral Therapy | journal | 1.624 Q1 | 93 | 118 | 164 | 4626 | 633 | 157 | 3.67 | 39.20 | |
| 12 | Controlled Clinical Trials | journal | 1.623 Q1 | 76 | 47 | 211 | 1406 | 480 | 181 | 2.20 | 29.91 | |
| 13 | Current Drug Metabolism | journal | 1.612 Q1 | 122 | 43 | 105 | 6141 | 492 | 99 | 4.74 | 142.81 | |
| 14 | Clinical Pharmacokinetics | journal | 1.578 Q1 | 184 | 73 | 250 | 6098 | 1586 | 246 | 6.53 | 83.53 | |
| 15 | Drug and Alcohol Dependence | journal | 1.533 Q1 | 187 | 148 | 419 | 6289 | 1487 | 410 | 3.35 | 42.49 |  |
| 16 | Journal of Antimicrobial Chemotherapy | journal | 1.435 Q1 | 221 | 465 | 1265 | 11630 | 4622 | 1023 | 3.72 | 25.01 | |
| 17 | Receptors and Channels | journal | 1.369 Q1 | 44 | 19 | 92 | 868 | 279 | 85 | 3.28 | 45.68 | |
| 18 | International Journal of Neuropsychopharmacology | journal | 1.338 Q1 | 125 | 70 | 155 | 2716 | 476 | 138 | 2.95 | 38.80 | |
| 19 | Pharmacogenomics Journal | journal | 1.284 Q1 | 95 | 58 | 174 | 2214 | 586 | 150 | 3.35 | 38.17 | |
| 20 | Drug Safety | journal | 1.211 Q1 | 140 | 94 | 264 | 6299 | 1152 | 253 | 4.12 | 67.01 | |
| 21 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 1.195 Q1 | 12 | 0 | 17 | 0 | 68 | 17 | 0.00 | 0.00 | |
| 22 | Current Opinion in Drug Discovery and Development | journal | 1.182 Q1 | 85 | 78 | 269 | 4338 | 911 | 252 | 3.77 | 55.62 | |
| 23 | American Journal of PharmacoGenomics | journal | 1.175 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 24 | Current Opinion in Molecular Therapeutics | journal | 1.175 Q1 | 67 | 87 | 263 | 4579 | 816 | 240 | 3.20 | 52.63 | |
| 25 | Antiviral Research | journal | 1.113 Q1 | 151 | 92 | 255 | 3664 | 916 | 253 | 3.57 | 39.83 | |
| 26 | Expert Opinion on Investigational Drugs | journal | 1.078 Q1 | 117 | 136 | 644 | 11132 | 2222 | 621 | 4.21 | 81.85 | |
| 27 | European Neuropsychopharmacology | journal | 1.037 Q1 | 130 | 87 | 247 | 3719 | 711 | 245 | 2.54 | 42.75 | |
| 28 | European Journal of Pharmacology | journal | 0.989 Q1 | 203 | 775 | 2292 | 31548 | 6186 | 2286 | 2.69 | 40.71 | |
| 29 | Pharmacogenomics | journal | 0.933 Q1 | 100 | 98 | 219 | 4704 | 572 | 188 | 2.56 | 48.00 | |
| 30 | Expert Opinion on Therapeutic Targets | journal | 0.930 Q1 | 106 | 54 | 162 | 4953 | 365 | 155 | 2.60 | 91.72 | |
| 31 | Investigational New Drugs | journal | 0.929 Q1 | 97 | 51 | 140 | 1478 | 345 | 137 | 2.22 | 28.98 | |
| 32 | Expert Opinion on Biological Therapy | journal | 0.928 Q1 | 102 | 170 | 292 | 13679 | 799 | 280 | 2.59 | 80.46 | |
| 33 | Journal of Psychopharmacology | journal | 0.923 Q1 | 135 | 81 | 188 | 3428 | 463 | 173 | 2.17 | 42.32 | |
| 34 | Cancer Chemotherapy and Pharmacology | journal | 0.920 Q1 | 122 | 167 | 462 | 5138 | 1117 | 461 | 2.40 | 30.77 | |
| 35 | PharmacoEconomics | journal | 0.907 Q1 | 118 | 121 | 318 | 5062 | 947 | 307 | 2.65 | 41.83 | |
| 36 | British Journal of Clinical Pharmacology | journal | 0.904 Q2 | 167 | 219 | 590 | 5397 | 1657 | 516 | 2.57 | 24.64 | |
| 37 | BMC Clinical Pharmacology | journal | 0.897 Q2 | 43 | 6 | 16 | 212 | 33 | 16 | 1.33 | 35.33 | |
| 38 | Current Drug Targets: Inflammation and Allergy | journal | 0.856 Q2 | 53 | 57 | 53 | 5459 | 143 | 53 | 2.70 | 95.77 | |
| 39 | Drug Discovery Today | journal | 0.851 Q2 | 215 | 380 | 1073 | 8164 | 2199 | 833 | 2.23 | 21.48 | |
| 40 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.833 Q2 | 99 | 136 | 468 | 5881 | 979 | 466 | 2.06 | 43.24 | |
| 41 | International Immunopharmacology | journal | 0.830 Q2 | 149 | 176 | 558 | 6732 | 1394 | 554 | 2.14 | 38.25 | |
| 42 | Planta Medica | journal | 0.788 Q2 | 135 | 255 | 800 | 4751 | 1563 | 798 | 1.77 | 18.63 | |
| 43 | Current Opinion in Investigational Drugs | journal | 0.780 Q2 | 83 | 158 | 449 | 7594 | 1156 | 418 | 2.66 | 48.06 | |
| 44 | Clinical and Experimental Pharmacology and Physiology | journal | 0.773 Q2 | 115 | 180 | 550 | 5535 | 1054 | 545 | 1.80 | 30.75 | |
| 45 | Journal of Antibiotics | journal | 0.773 Q2 | 92 | 112 | 440 | 1752 | 647 | 368 | 1.45 | 15.64 | |
| 46 | Journal of Ethnopharmacology | journal | 0.766 Q2 | 231 | 332 | 668 | 9722 | 1290 | 660 | 1.74 | 29.28 | |
| 47 | European Journal of Clinical Pharmacology | journal | 0.744 Q2 | 123 | 137 | 464 | 3671 | 1131 | 438 | 2.42 | 26.80 | |
| 48 | BioDrugs | journal | 0.737 Q2 | 79 | 35 | 172 | 3364 | 468 | 167 | 2.25 | 96.11 | |
| 49 | European Journal of Medicinal Chemistry | journal | 0.723 Q2 | 203 | 115 | 300 | 3234 | 656 | 299 | 1.86 | 28.12 |  |
| 50 | Xenobiotica | journal | 0.703 Q2 | 89 | 73 | 242 | 2773 | 518 | 240 | 1.90 | 37.99 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data